DCTPep06790 |
SEQ ID NO: 507 of Patent CN110785183A |
VYIAELEKI |
9 |
Synthetic |
DCTPep06791 |
SEQ ID NO: 508 of Patent CN110785183A |
IYVTGGHLF |
9 |
Synthetic |
DCTPep06792 |
SEQ ID NO: 509 of Patent CN110785183A |
ALLEEEEGV |
9 |
Synthetic |
DCTPep06793 |
SEQ ID NO: 510 of Patent CN110785183A |
KVLEHVVRV |
9 |
Synthetic |
DCTPep06794 |
SEQ ID NO: 511 of Patent CN110785183A |
KIWEELSVLEV |
11 |
Synthetic |
DCTPep06795 |
SEQ ID NO: 512 of Patent CN110785183A |
VLGEEQEGV |
9 |
Synthetic |
DCTPep06796 |
SEQ ID NO: 513 of Patent CN110785183A |
KLVELEHTL |
9 |
Synthetic |
DCTPep06797 |
SEQ ID NO: 514 of Patent CN110785183A |
VQLDSIEDLEV |
11 |
Synthetic |
DCTPep06798 |
SEQ ID NO: 515 of Patent CN110785183A |
KIFEMLEGV |
9 |
Synthetic |
DCTPep06799 |
SEQ ID NO: 516 of Patent CN110785183A |
YTFSGDVQL |
9 |
Synthetic |
DCTPep06800 |
SEQ ID NO: 517 of Patent CN110785183A |
TLYNPERTITV |
11 |
Synthetic |
DCTPep06801 |
SEQ ID NO: 518 of Patent CN110785183A |
GLLEDERALQL |
11 |
Synthetic |
DCTPep06802 |
SEQ ID NO: 519 of Patent CN110785183A |
KIQEILTQV |
9 |
Synthetic |
DCTPep06803 |
SEQ ID NO: 520 of Patent CN110785183A |
KIQEMQHFL |
9 |
Synthetic |
DCTPep06804 |
SEQ ID NO: 521 of Patent CN110785183A |
FVYGEPREL |
9 |
Synthetic |
DCTPep06805 |
SEQ ID NO: 522 of Patent CN110785183A |
TLDEKVAEL |
9 |
Synthetic |
DCTPep06806 |
SEQ ID NO: 523 of Patent CN110785183A |
HLIAEIHTA |
9 |
Synthetic |
DCTPep06807 |
SEQ ID NO: 524 of Patent CN110785183A |
KVWSDVTPL |
9 |
Synthetic |
DCTPep06808 |
SEQ ID NO: 525 of Patent CN110785183A |
RLDDLKMTV |
9 |
Synthetic |
DCTPep06809 |
SEQ ID NO: 526 of Patent CN110785183A |
VLSPFILTL |
9 |
Synthetic |
DCTPep06810 |
SEQ ID NO: 527 of Patent CN110785183A |
LLDSVSRL |
8 |
Synthetic |
DCTPep06811 |
SEQ ID NO: 528 of Patent CN110785183A |
RLLDSVSRL |
9 |
Synthetic |
DCTPep06812 |
SEQ ID NO: 529 of Patent CN110785183A |
HPSAHDVIL |
9 |
Synthetic |
DCTPep06813 |
SEQ ID NO: 530 of Patent CN110785183A |
APAAWLRSAA |
10 |
Synthetic |
DCTPep06814 |
TRAIL51-58 |
KSGIACFL |
8 |
TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand) |
DCTPep06815 |
TRAIL53-60 |
GIACFLKE |
8 |
TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand) |
DCTPep06816 |
TRAIL77-84 |
CWQVKWQL |
8 |
TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand) |
DCTPep06817 |
TRAIL198–206 |
NTKNDKQM |
8 |
TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand) |
DCTPep06818 |
TRAIL225-232 |
SARNSCWS |
8 |
TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand) |
DCTPep06819 |
TRAIL227–234 |
RNSCWSKD |
8 |
TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand) |